Amber lenses to block blue light and improve sleep: A randomized trial

Chronobiology International

Volumn 26, Issue 8, 2009, Pages 1602-1612

  Kimberly, Burkhart ^a   James R , Phelps ^b  

^a UNIVERSITY OF TOLEDO   (United States)

^b Samaritan Health Services   (United States)

Author keywords

Amber lenses; Blue light; Dark therapy; Insomnia; Sleep quality

Indexed keywords

ADOLESCENT; ADULT; AGED; CIRCADIAN RHYTHM; DARKNESS; EYEGLASSES; FEMALE; HUMANS; LIGHT; MALE; MIDDLE AGED; PHOTOBIOLOGY; PHOTORECEPTOR CELLS, VERTEBRATE; SLEEP; YOUNG ADULT;

EID: 73649084788     PISSN: 07420528     EISSN: 15256073     Source Type: Journal    
DOI: 10.3109/07420520903523719     Document Type: Article

References (34)

1. Barbini B, Benedetti F, Colombo C, Dotoli D, Bernasconi A, Cigala-Fulgosi M, Florita M, Smeraldi E. (2005). Dark therapy for mania: A pilot study. Bipolar Disord. 7:98-101.
2. Barron ML. (2007). Light exposure, melatonin secretion, and menstrual cycle parameters: An integrative review. Biol. Res. Nurs. 9:49-69.
3. Bauer M, Glenn T, Whybrow PC, Grof P, Rasgon N, Alda M, Marsh W, Sagduyu K, Schmid R, Adli M. (2008). Changes in self-reported sleep duration predict mood changes in bipolar disorder. Psychol. Med. 38:1069-1071.
4. Benedetti F, Dallaspezia S, Fulgosi MC, Colombo BBC, Smeraldi E. (2007). Phase advance is an actimetric correlate of antidepressant response to sleep deprivation and light therapy in bipolar depression. Chronobiol. Int. 24:921-937.
5. Blask DE. (2009). Melatonin, sleep disturbance and cancer risk. Sleep Med. Rev. 13:257-264.
6. Brainard GC, Hanifin JP, Greeson JM, Byrne B, Glickman G, Gerner E, Rollag MD. (2001). Action spectrum for melatonin regulation in humans: Evidence for a novel circadian photoreceptor. J. Neurosci. 21:6405-6412.
7. Casale TB, Blaiss MS, Gelfand E, Gilmore T, Harvey PD, Hindmarch I, Simons FE, Spangler DL, Szefler SJ, Terndrup TE, Waldman SA, Weiler J, Wong DF. (2003). Antihistamine Impairment Roundtable. First do no harm: Managing antihistamine impairment in patients with allergic rhinitis. J. Allergy Clin. Immunol. 111:S835-S842.
8. Dacey DM, Liao HW, Peterson BB, Robinson FR, Smith VC, Pokorny J, Yau KW, Gamlin PD. (2005). Melanopsin-expressing ganglion cells in primate retina signal colour and irradiance and project to the LGN. Nature 433:749-754.
9. Edinger JD, Wohlgemuth WK, Radtke RA, Coffman CJ, Carney CE. (2007). Dose-response effects of cognitive-behavioral insomnia therapy: A randomized clinical trial. Sleep 30:203-212.
10. Gooley JJ, Lu J, Fischer D, Saper CB. (2003). A broad role for melanopsin in nonvisual photoreception. J. Neurosci. 23:7093-7106.
11. Hallam K, Norman T, Olver J, Begg D. (2009). Abnormal dose-response melatonin suppression by light in Bipolar Type I patients compared with healthy adult subjects. Acta Neuropsychiatrica 21:246-255.
12. Hanifin JP, Stewart KT, Smith P, Tanner R, Rollag M, Brainard GC. (2006). High-intensity red light suppresses melatonin. Chronobiol. Int. 23:251-268.
13. Johnson EO, Roehrs T, Roth T, Breslau N. (1998). Epidemiology of alcohol and medication as aids to sleep in early adulthood. Sleep 21:178-186.
14. Kayumov L, Casper RF, Hawa RJ, Perelman B, Chung SA, Sokalsky S, Shapiro CM. (2005). Blocking low-wavelength light prevents nocturnal melatonin suppression with no adverse effect on performance during simulated shift work. J. Clin. Endocrinol. Metab. 90:2755-2761.
15. Lewy AJ, Lefler BJ, Emens JS, Bauer VK. (2006). The circadian basis of winter depression. Proc. Natl. Acad. Sci. USA 103:7414-7419.
16. Lockley SW. (2007). Safety considerations for the use of blue-light blocking glasses in shift-workers. J. Pineal Res. 42:210-211.
17. Lockley SW, Brainard GC, Czeisler CA. (2003). High sensitivity of the human circadian melatonin rhythm to resetting by short wavelength light. J. Clin. Endocrinol. Metab. 88:4502-4505.
18. Mahoney D. (2004). Red contact lenses help relieve acute migraine. Fam. Pract. News 34:59.
19. Mai E, Buysse DJ. (2008). Insomnia: Prevalence, impact, pathogenesis, differential diagnosis, and evaluation. Sleep Med. Clin. 3:167-174.
20. Perlis ML, Smith MT. (2008). How can we make CBT-I and other BSM services widely available? J. Clin. Sleep Med. 4:11-13.
21. Phelps J. (2008a). Bipolar disorder, light, and darkness: Treatment implications. Available at: http://www.psycheducation.org/depression/LightDark. htm#UVEX (accessed December 28, 2008).
22. Phelps J. (2008b). Dark therapy for bipolar disorder using amber lenses for blue light blockade. Med. Hypotheses 70:224-229.
23. Plante DT, Winkelman JW. (2008). Sleep disturbance in bipolar disorder: Therapeutic implications. Am. J. Psychiatry 165:830-843.
24. Portaluppi F, Touitou Y, Smolensky MH. (2008). Ethical and methodological standards for laboratory and medical biological rhythm research. Chronobiol. Int. 25:999-1016.
25. Revell VL, Skene DJ. (2007). Light-induced melatonin suppression in humans with polychromatic and monochromatic light. Chronobiol. Int. 24:1125-1137.
26. Rosenberg RP. (2006). Sleep maintenance insomnia: Strengths and weaknesses of current pharmacologic therapies. Ann. Clin. Psychiatry 18:49-56.
27. Sample PA, Esterson FD, Weinreb RN, Boynton RM. (1988). The aging lens: In vivo assessment of light absorption in 84 human eyes. Invest. Ophthalmol. Vis. Sci. 29:1306-1311.
28. Sasseville A, Paquet N, Sévigny J, Hébert M. (2006). Blue blocker glasses impede the capacity of bright light to suppress melatonin production. J. Pineal Res. 41:73-78.
29. Thapan K, Arendt J, Skene DJ. (2001). An action spectrum for melatonin suppression: Evidence for a novel non-rod, non-cone photoreceptor system in humans. J. Physiol. 535:261-267.
30. Watson D, Clark LA, Tellegen A. (1988). Development and validation of brief measures of positive and negative affect: The PANAS scale. J. Pers. Soc. Psychol. 54:1063-1070.
31. Wehr TA, Turner EH, Shimada JM, Lowe CH, Barker C, Leibenluft E. (1998). Treatment of rapidly cycling bipolar patient by using extended bed rest and darkness to stabilize the timing and duration of sleep. Biol. Psychiatry 43:822-828.
32. Weissman MM, Sholomskas D, Pottenger D, Prusoff BA, Locke BZ (1977). Assessing depressive symptoms in five psychiatric populations: A validation study. Am J Epidemiol. 106:203-214.
33. Wirz-Justice A. (2009). From the basic neuroscience of circadian clock function to light therapy for depression: On the emergence of chronotherapeutics. J. Affect. Disord. 116:159-160.
34. Wirz-Justice A, Quinto C, Cajochen C, Werth E, Hock C. (1999). A rapid-cycling bipolar patient treated with long nights, bedrest, and light. Biol. Psychiatry 45:1075-1077.